Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Airway mucosa hydration refers to the maintenance of an optimal level of water content in the mucus layer that lines the respiratory tract. This process is not a single molecular target but rather a physiological state regulated by multiple molecular mechanisms. Proper mucus hydration is essential for effective mucociliary clearance—the process by which cilia move hydrated mucus out of the airways, trapping and removing inhaled pathogens and debris[1][2]. The balance is maintained through active transepithelial ion transport—primarily chloride secretion via CFTR channels and sodium absorption via ENaC—which drives water movement across the epithelium[2][4]. Disruption in these processes leads to dehydrated, viscous mucus that impairs clearance and contributes to diseases such as cystic fibrosis, COPD, and asthma[1][3][5]. Because "airway mucosa hydration" describes a physiological property rather than a discrete molecule or receptor, it should not be considered a canonical therapeutic target like an enzyme or receptor. Instead, drug development efforts focus on modulating underlying molecular targets involved in regulating this property—such as CFTR chloride channels or ENaC sodium channels—to restore proper airway surface liquid volume. In summary: "Airway mucosa hydration" is not itself a molecule/receptor but represents an important physiological parameter controlled by several molecular targets involved in ion transport across airway epithelia. Therapeutics aim at these underlying proteins rather than at "airway mucosa hydration" directly[1][2][4]. If you need structured information about specific molecules regulating this process—such as "Epithelial sodium channel subunit alpha" (ENaC) or "Cystic fibrosis transmembrane conductance regulator" (CFTR)—please specify which one you are interested in.
Enhancement of epithelial ion transport to increase water movement into the airway lumen; Inhibition or modulation of epithelial sodium channel (ENaC) activity to reduce fluid absorption and promote mucus hydration.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Airway mucosa hydration.